Global Aptamers Market, By Type (DNA Aptamers, XNA Aptamers, RNA Aptamers), By Technology (SELEX, Others), By Technology (Therapeutics Development, Research & Development, Diagnostic, Others) and opportunities and forecast 2020-2027
Aptamers Market Overview
While antibodies have certain limitations in targeting small molecules, aptamers perform better in targeting small molecules. they can bind to little molecules and dyes and thus be easily utilized in typical diagnostic kits, extending their use to point-of-care diagnostics. This, in turn, can ensure a greater market value and increase in acceptance of aptamers in addressing each therapeutic and diagnostic applications. Also, aptamers will bind to ensure molecules. Nearly 98 of the molecules tend to be proteins, making it easier to find biomarkers and diagnostic kits. Antibodies are developed by raising an immune response in an animal model or DNA technology. On the other hand, aptamers can be synthesized using chemical ways that are less expensive. Therefore, aptamers are additional appealing for the event of latest therapeutic drugs and diagnostic kits.
The blood-brain barrier has been a great challenge for antibody-based treatment for neurodegenerative disorders like Alzheimer’s. although technological developments have bridged the gap for this challenge, the effectiveness of antibodies against these disorders remains intact. Aptamers are short oligonucleotides that may diffuse across this barrier and show potential in treating neurodegenerative disorders. Furthermore, antibodies may cause an immunogenic response against the host, resulting in serious side-effects. In distinction, aptamers are non-immunogenic and far safer. Aptamers additionally offer various advantages such as lower price of production, easy planning & synthesis, and high potency. These factors create them relatively economical. The scale-up is additionally huge and so shows significant potential within the development of therapeutics.
Many aptamer development companies are identifying the potential of aptamers to be used in therapeutic and diagnostic applications. These players are currently focusing on securing funding from varied investors to expand their offerings and strengthen their positions within the market. Therefore, increasing venture capital funding is projected to drive the growth of the market.
The covid-19 Impact on Aptamers Market:
|Market size available for years
|Base year considered
||Value (USD Million)
||Type, Technology, Application and Region
||North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA)
||Aptamer Group, Raptamer Discovery Group, SomaLogic Inc. , Aptamer Sciences, Inc. and Aptagen, LLC .
Like several different industries, COVID-19 badly knocked the electronic and semiconductor trade. This new event has compact nearly 230 countries in exactly a couple of weeks, leading to the forced conclusion of producing and transportation activities at intervals and across the countries. This has directly affected the expansion of the sector. It's calculable that COVID-19 to depart over USD thirty billion impacts on the physics and semiconductor trade. The arena is majorly affected thanks to transport restrictions on major physics and semiconductor staple suppliers. However, the rising want for semiconductors in many industries can supply fast market recovery over the longer-term amount. Aptamers Market Segment Overview
By type, the aptamers market is divided into DNA aptamers, XNA aptamers, and RNA aptamers. The DNA-based aptamers segment dominated the market in 2020. the large share of this phase is attributed to their lower cost and better stability compared to alternative nucleic acid-based aptamers and also the wide handiness of DNA aptamers.
By technology, the aptamers market is divided into SELEX and alternative technologies. The SELEX technology phase dominated the market in 2020. The phase accounts for an oversized share of the aptamers market as SELEX is one in all the foremost wide used technologies. the opposite technologies phase is anticipated to register the best CAGR throughout the forecast amount because of the increasing specialise in developing technologies for aptamer choice.
By application, the aptamers market is divided into medicine development, analysis & development, diagnostics, and other applications. In 2020, the medicine development phase dominated the market because of the increasing variety of clinical trials evaluating aptamers for brand new therapies and collaborations among aptamer firms & distinguished pharmaceutical and biotechnology companies. The diagnostic phase is projected to grow at the best CAGR because of the increasing prevalence of chronic diseases and also the development of recent diagnostic kits to observe cancer and alternative diseases.
Market Analysis, Insights and Forecast – By Type
· DNA Aptamers
· XNA Aptamers
· RNA Aptamers
Market Analysis, Insights and Forecast – By Technology
Market Analysis, Insights and Forecast – By Application
· Therapeutics Development
· Research & Development
· OthersAptamers Market Regional Overview
Region-wise, in terms of regions, Asia Pacific market to witness the best growth throughout the forecast amount . In 2020, North America accounted for the biggest share of this market. the largest share of North America is attributed to the supply of funds to develop innovative technologies, the presence of prominent market players, and growing collaborations among firms. The Asia Pacific market is calculable to record the best CAGR throughout the forecast amount. this can be attributed to the rising R&D activities on aptamers, the event of aptamer-based product, and also the rising focus on drug discovery and development.
Aptamers Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA) Aptamers Market Competitor overview
Some key developments and strategies adopted by manufacturers in the Aptamers are highlighted below.
· In 2021, Aptamer group, Ltd. and BizCom Japan, Inc. entered into a distribution and marketing agreement to promote Optimer discovery and development services in Japan. Aptamers Market, Key Players
· Aptamer Group
· Raptamer Discovery Group
· SomaLogic Inc.
· Aptamer Sciences, Inc.
· Aptagen, LLC .
Frequently Asked Questions (FAQ) :
Q1. What is the total CAGR expected to be recorded for the Aptamers market during the forecast period?
A. Aptamers market is expected to record a CAGR of ~17.9% during the forecast period
Q2. Which segment is projected to hold the largest share in the Aptamers Market?
A. SELEX segment is projected to hold the largest share in the Aptamers Market
Q3. What are the driving factors for the Aptamers market?
A. Antibodies are developed by raising an immune response in an animal model or DNA technology. On the other hand, aptamers can be synthesized using chemical ways that are less expensive is key factors that boost the growth of the Aptamers market progressively
Q4. Which Segments are covered in the Aptamers market report?
A. Type, Technology ,Application and Region, these segments are covered in the Aptamers market report
Q5. Which are the prominent players offering Aptamers?
A. Aptamer Group,Raptamer Discovery Group , SomaLogic Inc. , Aptamer Sciences, Inc. and Aptagen, LLC